Gufic Biosciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
GUFICBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gufic Biosciences has informed the stock exchanges that its trading window will remain closed for designated persons and their immediate relatives starting Wednesday, October 1, 2025. The closure will stay in effect until 48 hours after the company declares its Unaudited Financial Results (both standalone and consolidated) for the quarter and half year ended September 30, 2025. The board meeting date to approve these Q2/H1 FY26 results will be communicated separately in due course. This is a routine compliance filing under SEBI's insider trading regulations and signals that the company's quarterly earnings announcement is approaching.
This is a standard regulatory disclosure with no direct impact on shareholders or the stock price. It simply indicates that Q2 FY26 results are likely to be announced in the next few weeks, which investors should watch for.